However, their sensitivity and specificity are limited, and traditional markers such as carcinoembryonic antigen (CEA) and cancer antigen 19–9 (CA19-9) have demonstrated ineffectiveness in the early detection of GC (Nakamura et al., 2019). The gene discussed is CEACAM5; the disease is cancer.